Adjuvant therapy in pancreatic cancer. - Wikidata - awgldk - TriplyDB

Adjuvant therapy in pancreatic cancer.

Adjuvant therapy in pancreatic cancer.

http://www.wikidata.org/entity/Q34405072

about

Activator protein 1 promotes gemcitabine‑induced apoptosis in pancreatic cancer by upregulating its downstream target Bim FFCD-1004 Clinical Trial: Impact of Cytidine Deaminase Activity on Clinical Outcome in Gemcitabine-Monotherapy Treated Patients Pancreatic cancer incidence and mortality patterns in China, 2011.The prognostic influence of intrapancreatic tumor location on survival after resection of pancreatic ductal adenocarcinoma MicroRNA-301a-3p promotes pancreatic cancer progression via negative regulation of SMAD4.Tumor-associated macrophage-derived CCL20 enhances the growth and metastasis of pancreatic cancer.Meta-analysis of adjuvant therapy following curative surgery for periampullary adenocarcinoma.Laparoscopic distal pancreatectomy for pancreatic ductal adenocarcinoma: results of a multicenter cohort study on 196 patients.Lin28B facilitates the progression and metastasis of pancreatic ductal adenocarcinoma.Identification of Sox6 as a regulator of pancreatic cancer development.Potential functions and implications of circular RNA in gastrointestinal cancer.Superior efficacy of the antifungal agent ciclopirox olamine over gemcitabine in pancreatic cancer models.Proteome Profiling of Primary Pancreatic Ductal Adenocarcinomas Undergoing Additive Chemoradiation Link ALDH1A1 to Early Local Recurrence and Chemoradiation Resistance

P2860

Q28468378-5C49CD81-D88B-4F2C-89A1-8B5D824013FF Q28547481-BCCE6C1A-5E4A-4DE0-B263-60DCF8F95B19 Q35085499-76588F0C-5617-4732-A280-B2D034CB2C06 Q35854942-7969DDBD-3770-432E-9313-A12C3F882BE9 Q36356232-49F20241-6ACF-489D-BB46-D90A5FDA3FA9 Q38734966-DA24F82D-D0F1-43D3-A442-1FD94DF93CFA Q39314886-1CA9C8FF-7EFD-42DD-8676-7074884DF6D9 Q40379185-C63C9B39-30A8-4DBD-A30B-245E73F5D7BD Q41694110-B8097E30-1275-4087-96A9-5898F961A614 Q48166983-BEC97803-8E29-431B-A4AB-8A24A96C3BF6 Q49523244-76BF67AB-C1F8-45B0-9518-E20A7FB9EA98 Q52657095-7C1ACACC-D305-4F45-970C-CBC7FAF3348D Q56761472-D1A0F8D2-6198-416F-8F9A-E2F8FCD9864E

P2860

Adjuvant therapy in pancreatic cancer.

http://www.wikidata.org/entity/Q34405072

description

2014 nî lūn-bûn

@nan

2014 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Adjuvant therapy in pancreatic cancer.

@ast

Adjuvant therapy in pancreatic cancer.

@en

Adjuvant therapy in pancreatic cancer.

@nl

type

label

Adjuvant therapy in pancreatic cancer.

@ast

Adjuvant therapy in pancreatic cancer.

@en

Adjuvant therapy in pancreatic cancer.

@nl

prefLabel

Adjuvant therapy in pancreatic cancer.

@ast

Adjuvant therapy in pancreatic cancer.

@en

Adjuvant therapy in pancreatic cancer.

@nl

P1433

Q34405072-9203B88A-C2BF-4711-AC51-3F8F5A8F882B

P1476

Q34405072-7A094953-15FB-4862-853B-89184236C185

P2093

Q34405072-0441FC33-E167-4530-849A-3B0B068FC6BF

Q34405072-4B22C43B-80C0-4673-B32C-4C81FE6759F3

Q34405072-7101F35E-43A5-44C1-9C52-58242ED84949

P2860

Q34405072-00D8D869-B938-40F0-ACB2-29D377802628

Q34405072-146B1758-9BE6-4754-A86C-FFFDEA2D9B5E

Q34405072-14A7196F-A6AD-4333-967D-E90D8CBD86D9

Q34405072-1C26C8D3-D102-4B55-9FA9-34F51DA2D812

Q34405072-1FB4B960-AE81-4461-84BA-F544114957C4

Q34405072-2015DB28-1A3E-4352-9589-435D43465D2A

Q34405072-2A58E4AD-DF6D-424D-9165-8D810658252B

Q34405072-2D32F405-F4CD-4D29-8258-508134862120

Q34405072-306C3FE6-8F52-4E5E-874B-E5E38A978955

Q34405072-34FAEB1E-4ED4-4D7E-9F7A-E6C6E61CF7BD

P304

Q34405072-66A00E1C-C701-414D-94C2-5E20E19B6A6C

P31

Q34405072-F1AB905B-E322-4232-8129-CBC1B6651848

P356

Q34405072-B0D84382-2624-42CF-A208-E18B13D4047C

P407

Q34405072-F464C8A9-9D48-4736-8EE3-BF79BD1F99FF

P433

Q34405072-A389F4AA-C642-4F3C-8122-5543C55F83D6

P478

Q34405072-30A8EE7B-CD0A-4D99-B6EF-1071A3311DCE

P577

Q34405072-EDF9C6D5-72AE-45D8-8213-460B08A19F60

P5875

Q34405072-EE6E7584-9AE9-443A-B5A1-C9922C10705D

P698

Q34405072-A47162C2-E581-4684-8E72-C13BF2ACEB02

P932

Q34405072-6EAE5943-4524-4974-9383-1A70CA8FFF99

P356

WJG.V20.I40.14733

P1433

World Journal of Gastroenterology

P1476

Adjuvant therapy in pancreatic cancer.

@en

P2093

James Daniel Melling

http://www.w3.org/2001/XMLSchema#string

Owain Peris Jones

http://www.w3.org/2001/XMLSchema#string

Paula Ghaneh

http://www.w3.org/2001/XMLSchema#string

P2860

Cancer statistics, 2007

Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial

FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer

Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine

Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: a phase III trial of the National Cancer Institute of Canada Clinical Trials Group

Fluorouracil-based chemoradiation with either gemcitabine or fluorouracil chemotherapy after resection of pancreatic adenocarcinoma: 5-year analysis of the U.S. Intergroup/RTOG 9704 phase III trial.

Radiation therapy is associated with improved survival in patients with pancreatic adenocarcinoma: results of a study from the Surveillance, Epidemiology, and End Results (SEER) registry data.

Adjuvant 5-fluorouracil and folinic acid vs observation for pancreatic cancer: composite data from the ESPAC-1 and -3(v1) trials

Adjuvant chemotherapy with fluorouracil plus folinic acid vs gemcitabine following pancreatic cancer resection: a randomized controlled trial.

Is postoperative adjuvant chemotherapy useful for gallbladder carcinoma? A phase III multicenter prospective randomized controlled trial in patients with resected pancreaticobiliary carcinoma.

P304

14733-14746

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3748/WJG.V20.I40.14733

http://www.w3.org/2001/XMLSchema#string

P407

P433

40

http://www.w3.org/2001/XMLSchema#string

P478

20

http://www.w3.org/2001/XMLSchema#string

P577

2014-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

267735460

http://www.w3.org/2001/XMLSchema#string

P698

25356036

http://www.w3.org/2001/XMLSchema#string

P932

4209539

http://www.w3.org/2001/XMLSchema#string